Isis falls on drug results
Shares of Isis Pharmaceuticals fell nearly 6 percent Tuesday after the Carlsbad biotech announced early Phase 2 results for its experimental diabetes drug. Isis closed at $64.70, down $3.97 for the day. Shares had fallen as low as $61.58. With a market …